Anti-Siglec-2 / CD22 Reference Antibody (inotuzumab-CLM) | Ubiquitin Ligase-ubiquitin-ligase.com

Product Name :
Anti-Siglec-2 / CD22 Reference Antibody (inotuzumab-CLM)

synonym :
null,

productDescription :
Anti-Siglec-2 / CD22 Reference Antibody (inotuzumab-CLM)(CHB255) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 144.78 kDa.

molecularWeight :
146.48 kDa

endotoxin :
<0.001 EU/ug

purity :
>95%

formulation :
100 mM Pro-Ac 20mM Arg pH 5.0

storage :
-80°C for 2 years under sterile conditions； -20°C for 1 year under sterile conditions；Avoid repeated freeze-thaw cycles.

reactivity :
Human

concentration :
1 mg/ml

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
IL-18 Antibody
SOD2 Antibody (YA670)
RBPJK Antibody: RBPJK Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 56 kDa, targeting to RBPJK. It can be used for WB assays with tag free, in the background of Human.

Author: Ubiquitin Ligase- ubiquitin-ligase

Related Posts